G. Attard

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

Lewis Au, Emine Hatipoglu, Marc Robert de Massy et al. · Cancer Cell · 2021 · 256 citations · Full text

Life Sciences, Immunology, Oncology +17

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.

Howard I. Scher, Glenn Heller, Ana M. Molina et al. · Journal of Clinical Oncology · 2011 · 113 citations

Medicine, Oncology, Pharmacology +17

Electrooxidation of ethanol at polycrystalline and platinum stepped single crystals: A study by differential electrochemical mass spectrometry

Ehab Mostafa, S.E. Huxter, G. Attard et al. · Electrochimica Acta · 2010 · 83 citations

Natural Sciences, Chemistry, Materials Science +12

Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

Kevin Litchfield, Stacey Stanislaw, Lavinia Spain et al. · Cell Reports · 2020 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols

Francesca Schiavone, Riya Bathia, Krishna Letchemanan et al. · Trials · 2019 · 62 citations · Full text

Medicine, Biostatistics, Clinical Data Management +15